Jonathan Berlent brings over twenty five years of strategic leadership and operations expertise in the biotechnology and pharmaceutical arena to his role as Senior Vice President, Head of Strategy and Operations at Merakris Therapeutics. With a proven track record of driving growth through corporate initiatives expanding product portfolios and driving market presence, Jonathan is poised to propel Merakris’ continued growth.
Most recently, Jonathan served as the President of Sentiss Pharmaceuticals’ North American Operations. Sentiss is a sterile ophthalmic developer, manufacturer and distributor of pharmaceutical products where he led the company to their first US FDA product approval, spearheaded the company’s strategic growth through R&D portfolio expansion in ophthalmology and through asset acquisition, and expanded development into injectables.